Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 326-350 of 734 matching filings.

Per page
25
Current page
14
4

4

Filing date
04 Oct 2023
Reporting date
02 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Oct 2023
Reporting date
02 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Sep 2023
Reporting date
13 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91047

SC 13G/A filing

Filing date
12 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Aug 2023
Reporting date
30 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Aug 2023
Reporting date
28 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
28 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Aug 2023
Reporting date
08 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Aug 2023
Reporting date
01 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
01 Aug 2023
Reporting date
28 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jul 2023
Reporting date
03 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
27 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jun 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .